Home » Topics » BioWorld

BioWorld
RSS

ASAHI LICENSES CELLECTOR TECHNOLOGY

April 17, 1992

MGI GIVES UP ON MGI 136

April 17, 1992

CENTOXIN COULD DELAY SECOND SEPSIS DRUG

April 17, 1992

SYNAPTIC FINDS GENE FOR NERVE CELL RECEPTOR

April 17, 1992

SYNTRO SHRINKS OFFERING AS WINDOW CLOSES

April 17, 1992

BIOTECH SELL-OFF: BAD, BUT NOT TERRIBLE

April 16, 1992

IMMUNOGEN STARTS EUROPEAN TRIALS

April 16, 1992

IMMURAID GETS ORPHAN DESIGNATION

April 16, 1992

SEPRACOR PATENT COVERS PROZAC ISOMER

April 16, 1992

FDA DEMANDS NEW TRIAL FOR CENTOXIN

April 16, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...